ARCHIVES

Three Institutes To Test BioMicro’s Microarray Product. GlycoDesign Allowed Patent For Cancer Drug GD0039.

This article is from The Cancer Letter archive.

Vol. 28 No. 09 | March 1, 2002

Download PDF Visit The Full Archive

Related Articles

Cancer Center In Russia Seeks Cancer Drugs, Other Supplies, From US

July 30, 1993

GAO Suggest NIG Stop Automatic Funding Of Non Competing Grants, Pay Higher Percent Of New Grants

August 13, 1976

Wyngaarden Helps Make Case For Facilities Funding, Reveals Plan For New NIH Building

April 15, 1988

NCI Advisory Group, Other Cancer Meetings

January 2, 1981

Letter To the Editor; Closed Meetings Create Aura of Suspicion

August 12, 1994

Varmus, Duke Ask IOM To Investigate Potti’s Scientific Work, Clinical Trials

July 30, 2010